Clinical Trials Logo

Clinical Trial Summary

To test whether slowing the rate of delivery of inulin with either psyllium or divided dosing of inulin, will reduce colonic gas production as compared to inulin combined with placebo. To obtain pilot data on link between habitual diet and fermentation of inulin.


Clinical Trial Description

Our challenge is to understand how fibre interacts with whole-gut function to alter colonic fermentation of fermentable oligo-di-mono-saccharides and polyhydric alcohols (FODMAPs). We have previously performed the study entitled the Effect of modified Cellulose On COlonic fermentAtion of inulin (COCOA) in which a modified methylcellulose (food grade product -modified celluloses- which can form gels at body temperature ) was used and showed some reduction, but this was not statistically significant, and much less than with psyllium. We wish to determine whether slowing delivery of inulin will produce a lowering of breath hydrogen equivalent to that seen with psyllium. We also found that the breath hydrogen curve had not shown a consistent fall by 6 hours suggesting that 6 hours was not long enough to accurately define the area under the curve (AUC). We now plan to use breath sampling bags to collect breath samples at home to define the breath hydrogen response over whole 24-hour period post ingestion of test drink. We also hypothesise that the colonic microbiota will influence the fermentation of inulin and will collect stool samples to allow future work to correlate microbiota with fermentation rates as part of a separate Medical Research Council funded study. Aim Our aim is to test the hypothesis that slowing delivery of inulin will achieve a similar reduction in breath hydrogen production over the 24 hours following ingestion as seen when co-administered with psyllium. Objective The primary objective is to compare the effect of bolus administration of inulin (co-administrated with psyllium or maltodextrin placebo) with divided dose delivery of inulin over 6 hours on total gas production over 24 hours. Secondary Objectives Secondary objectives will be 1) to compare breath hydrogen AUC 0-24h with values based on AUC 0-6h that was assessed in the previous study (COCOA) to see how much the shorter period underestimates H2 production; 2) to assess breath methane production AUC 0-24h after consumption of test drinks; and 3) to collect pilot data on habitual dietary FODMAPs intake to assess whether this alters fermentation of inulin. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05619341
Study type Interventional
Source University of Nottingham
Contact
Status Completed
Phase N/A
Start date October 28, 2022
Completion date April 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT06006715 - Psychiatric Disorders and Functional Somatic Disorders
Completed NCT05811663 - Health Care Use and Costs of Functional Somatic Disorders
Enrolling by invitation NCT04011943 - Fecal Microbiota Transplantation for Health Improvement (TFM3) N/A
Completed NCT04245254 - GutMe!: IBS and Collagen Protein Powder an Interventional Study N/A
Recruiting NCT04214470 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Completed NCT02742597 - Patient-Centred Innovations for Persons With Multimorbidity - Ontario N/A
Completed NCT03046667 - Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal Health N/A
Active, not recruiting NCT05463900 - Microbial and Human Determinants of the Onset of IBD Flares
Completed NCT02789800 - Patient-Centred Innovations for Persons With Multimorbidity - Quebec N/A